Cargando…
The effect of hemodialysis on ocular changes in patients with the end-stage renal disease
Background: Numerous metabolic parameters can be changed during hemodialysis in the end-stage renal disease (ESRD) caused by systemic diseases, such as diabetes mellitus, hypertension. Some ocular parameters also can be variable due to the changes after hemodialysis. This study evaluates the effects...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609354/ https://www.ncbi.nlm.nih.gov/pubmed/31269848 http://dx.doi.org/10.1080/0886022X.2019.1635494 |
_version_ | 1783432299685085184 |
---|---|
author | Sun, Guijiang Hao, Rui Zhang, Longli Shi, Xueying Hei, Kaiwen Dong, Lijie Wei, Fang Jiang, Aili Li, Bo Li, Xiaorong Ke, Yifeng |
author_facet | Sun, Guijiang Hao, Rui Zhang, Longli Shi, Xueying Hei, Kaiwen Dong, Lijie Wei, Fang Jiang, Aili Li, Bo Li, Xiaorong Ke, Yifeng |
author_sort | Sun, Guijiang |
collection | PubMed |
description | Background: Numerous metabolic parameters can be changed during hemodialysis in the end-stage renal disease (ESRD) caused by systemic diseases, such as diabetes mellitus, hypertension. Some ocular parameters also can be variable due to the changes after hemodialysis. This study evaluates the effects of ocular parameters, including best-corrected visual acuity (BCVA), intraocular pressure (IOP), central macular thickness (CMT), subfoveal choroidal thickness (SFCT), retinal arteriolar caliber (RAC), retinal venular calibre (RVC), in ESRD patients following hemodialysis. Materials and methods: Two-hundred and two ESRD patients were recruited resulting in 404 eyes evaluations. All patients underwent hemodialysis in the Dialysis Unit of the Second Hospital of Tianjin Medical University. BCVA, CMT, IOP, SFCT, RAC and RVC were evaluated before and after hemodialysis. Systemic parameters were collected such as age, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), duration of hemodialysis, body weight changes, high density lipoprotein cholesterol (HDLC), low density lipoprotein cholesterol (LDLC), very low density lipoprotein cholesterol (VLDLC), glycosylated hemoglobin (HbA1c). Results: The causes of ESRD patients included chronic glomerulonephritis (n = 65), diabetes mellitus (n = 60), hypertensive nephrosclerosis (n = 37), and other causes (n = 40). In our study, BCVA (p = .817), CMT (p = .252) and IOP (p = .978) did not significantly change after hemodialysis. SFCT significantly decreased from 254.29 ± 69.36 μm to 235.54 ± 659.90 μm (p = .002) following hemodialysis. SFCT changes were significantly correlated with SBP (p = .042) and body weight changes (p = .044). The RAC and RVC were dilated significantly (p = .033, p = .007). RVC changes were correlated with baseline DBP (p = .003), HDLC (p = .009), LDLC (p = .004) and changes in DBP (p = .037) and body weight (p = .001). Conclusion: Hemodialysis can affect various ocular parameters including SFCT, RAC and RVC, which changed significantly following hemodialysis. Whereas BCVA, IOP and CMT did not change after hemodialysis in ESRD patients. The systemic compensatory mechanisms of the changes in SBP, DBP, body weight following hemodialysis need further study. |
format | Online Article Text |
id | pubmed-6609354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-66093542019-07-12 The effect of hemodialysis on ocular changes in patients with the end-stage renal disease Sun, Guijiang Hao, Rui Zhang, Longli Shi, Xueying Hei, Kaiwen Dong, Lijie Wei, Fang Jiang, Aili Li, Bo Li, Xiaorong Ke, Yifeng Ren Fail Clinical Study Background: Numerous metabolic parameters can be changed during hemodialysis in the end-stage renal disease (ESRD) caused by systemic diseases, such as diabetes mellitus, hypertension. Some ocular parameters also can be variable due to the changes after hemodialysis. This study evaluates the effects of ocular parameters, including best-corrected visual acuity (BCVA), intraocular pressure (IOP), central macular thickness (CMT), subfoveal choroidal thickness (SFCT), retinal arteriolar caliber (RAC), retinal venular calibre (RVC), in ESRD patients following hemodialysis. Materials and methods: Two-hundred and two ESRD patients were recruited resulting in 404 eyes evaluations. All patients underwent hemodialysis in the Dialysis Unit of the Second Hospital of Tianjin Medical University. BCVA, CMT, IOP, SFCT, RAC and RVC were evaluated before and after hemodialysis. Systemic parameters were collected such as age, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), duration of hemodialysis, body weight changes, high density lipoprotein cholesterol (HDLC), low density lipoprotein cholesterol (LDLC), very low density lipoprotein cholesterol (VLDLC), glycosylated hemoglobin (HbA1c). Results: The causes of ESRD patients included chronic glomerulonephritis (n = 65), diabetes mellitus (n = 60), hypertensive nephrosclerosis (n = 37), and other causes (n = 40). In our study, BCVA (p = .817), CMT (p = .252) and IOP (p = .978) did not significantly change after hemodialysis. SFCT significantly decreased from 254.29 ± 69.36 μm to 235.54 ± 659.90 μm (p = .002) following hemodialysis. SFCT changes were significantly correlated with SBP (p = .042) and body weight changes (p = .044). The RAC and RVC were dilated significantly (p = .033, p = .007). RVC changes were correlated with baseline DBP (p = .003), HDLC (p = .009), LDLC (p = .004) and changes in DBP (p = .037) and body weight (p = .001). Conclusion: Hemodialysis can affect various ocular parameters including SFCT, RAC and RVC, which changed significantly following hemodialysis. Whereas BCVA, IOP and CMT did not change after hemodialysis in ESRD patients. The systemic compensatory mechanisms of the changes in SBP, DBP, body weight following hemodialysis need further study. Taylor & Francis 2019-07-04 /pmc/articles/PMC6609354/ /pubmed/31269848 http://dx.doi.org/10.1080/0886022X.2019.1635494 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Sun, Guijiang Hao, Rui Zhang, Longli Shi, Xueying Hei, Kaiwen Dong, Lijie Wei, Fang Jiang, Aili Li, Bo Li, Xiaorong Ke, Yifeng The effect of hemodialysis on ocular changes in patients with the end-stage renal disease |
title | The effect of hemodialysis on ocular changes in patients with the end-stage renal disease |
title_full | The effect of hemodialysis on ocular changes in patients with the end-stage renal disease |
title_fullStr | The effect of hemodialysis on ocular changes in patients with the end-stage renal disease |
title_full_unstemmed | The effect of hemodialysis on ocular changes in patients with the end-stage renal disease |
title_short | The effect of hemodialysis on ocular changes in patients with the end-stage renal disease |
title_sort | effect of hemodialysis on ocular changes in patients with the end-stage renal disease |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609354/ https://www.ncbi.nlm.nih.gov/pubmed/31269848 http://dx.doi.org/10.1080/0886022X.2019.1635494 |
work_keys_str_mv | AT sunguijiang theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT haorui theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT zhanglongli theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT shixueying theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT heikaiwen theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT donglijie theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT weifang theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT jiangaili theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT libo theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT lixiaorong theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT keyifeng theeffectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT sunguijiang effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT haorui effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT zhanglongli effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT shixueying effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT heikaiwen effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT donglijie effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT weifang effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT jiangaili effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT libo effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT lixiaorong effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease AT keyifeng effectofhemodialysisonocularchangesinpatientswiththeendstagerenaldisease |